{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:59:04Z","timestamp":1781049544645,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00296-021-04833-3","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T21:44:51Z","timestamp":1616103891000},"page":"1199-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2480","authenticated-orcid":false,"given":"Figen","family":"\u00c7akmak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-6406","authenticated-orcid":false,"given":"Mustafa","family":"\u00c7akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9801-925X","authenticated-orcid":false,"given":"Ferhat","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-3068","authenticated-orcid":false,"given":"Hafize Emine","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-4279","authenticated-orcid":false,"given":"Sedat","family":"\u00c7akmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9950-2489","authenticated-orcid":false,"given":"Fatma Gul","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3232-0055","authenticated-orcid":false,"given":"\u015eerife G\u00fcl","family":"Karada\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray Aktay","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5644","authenticated-orcid":false,"given":"Bet\u00fcl","family":"S\u00f6zeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"4833_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767\u2013778","journal-title":"Lancet"},{"key":"4833_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"4833_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2005-915644","volume":"1","author":"BJ McMahon","year":"2005","unstructured":"McMahon BJ (2005) Epidemiology and natural history of hepatitis B. Semin Liver Dis 1:3\u20138","journal-title":"Semin Liver Dis"},{"key":"4833_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2478\/folmed-2018-0076","volume":"61","author":"MP Baymakova","year":"2019","unstructured":"Baymakova MP, Karcheva M (2019) Trends in the acute hepatitis B and acute hepatitis C in Bulgaria. Folia Med 61:197\u2013203","journal-title":"Folia Med"},{"key":"4833_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/njcp.njcp_368_16","volume":"21","author":"FA Igde","year":"2018","unstructured":"Igde FA, Taskin H, Igde M, Yazici Z, Atilla A (2018) Where we are in the fight against hepatitis B infection; trends in hepatitis B virus seroprevalence in Black Sea Region of Turkey. Niger J Clin Pract 21:87\u201392","journal-title":"Niger J Clin Pract"},{"key":"4833_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12879-020-05247-5","volume":"20","author":"A Acikgoz","year":"2020","unstructured":"Acikgoz A, Cimrin D, Kizildag S, Esen N, Balci P, Sayiner AA (2020) Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study. BMC Infect Dis 20:529","journal-title":"BMC Infect Dis"},{"key":"4833_CR7","doi-asserted-by":"publisher","unstructured":"Okay G, Biberci Keskin E, Akkoyunlu Y, Bolukcu S, Betul Uslu A, Meric Koc M (2020) Evaluation of hepatitis B vaccine efficacy and factors affecting vaccine nonresponse in patients receiving anti-tumor necrosis factor agents. Eur J Gastroenterol Hepatol. \u00a0https:\/\/doi.org\/10.1097\/MEG.0000000000001849","DOI":"10.1097\/MEG.0000000000001849"},{"key":"4833_CR8","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1080\/21645515.2015.1070999","volume":"11","author":"L Ozisik","year":"2015","unstructured":"Ozisik L, Tanriover MD, Calik Basaran N, Oz SG, Unal S (2015) Missed opportunities for Hepatitis B vaccination among diabetic patients. Hum Vaccines Immunother 11:2806\u20132810","journal-title":"Hum Vaccines Immunother"},{"key":"4833_CR9","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/21645515.2019.1574151","volume":"15","author":"A Haykir Solay","year":"2019","unstructured":"Haykir Solay A, Eser F (2019) High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study. Hum Vaccines Immunother 15:1177\u20131182","journal-title":"Hum Vaccines Immunother"},{"key":"4833_CR10","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG et al (2012) Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64:2773\u20132780","journal-title":"Arthritis Rheum"},{"key":"4833_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658\u2013666","journal-title":"Arthritis Rheum"},{"key":"4833_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","volume":"366","author":"AR Zanetti","year":"2005","unstructured":"Zanetti AR, Mariano A, Romano L, D\u2019Amelio R, Chironna M, Coppola RC et al (2005) Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366:1379\u20131384","journal-title":"Lancet"},{"key":"4833_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10654-006-0001-2","volume":"21","author":"E Gurol","year":"2006","unstructured":"Gurol E, Saban C, Oral O, Cigdem A, Armagan A (2006) Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 21:299\u2013305","journal-title":"Eur J Epidemiol"},{"key":"4833_CR14","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3855\/jidc.4102","volume":"7","author":"G Karatekin","year":"2013","unstructured":"Karatekin G, Kilin\u00e7 M, Gulcan \u00d6ksuz B, I\u011fde M (2013) Hepatitis B seroprevalence in children and women and the impact of the hepatitis B vaccination program in the Black Sea Region of Turkey. J Infect Dev Ctries 7:960\u2013965","journal-title":"J Infect Dev Ctries"},{"key":"4833_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5005\/jp-journals-10018-1264","volume":"8","author":"H Ozkan","year":"2018","unstructured":"Ozkan H (2018) Epidemiology of chronic hepatitis B in Turkey. Euroasian J Hepatogastroenterol 8:73\u201374","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"4833_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U et al (2015) Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 21:1020\u20131026","journal-title":"Clin Microbiol Infect"},{"key":"4833_CR17","first-page":"105","volume":"47","author":"G Kanra","year":"2005","unstructured":"Kanra G, Tezcan S, Badur S (2005) Hepatitis B and measles seroprevalence among Turkish children. The Turk J Pediatr 47:105\u2013110","journal-title":"The Turk J Pediatr"},{"key":"4833_CR18","first-page":"969","volume":"31","author":"D Maritsi","year":"2013","unstructured":"Maritsi D, Vartzelis G, Soldatou A, Garoufi A, Spyridis N (2013) Markedly decreased antibody titers against hepatitis B in previously immunised children presenting with juvenile idiopathic arthritis. Clin Exp Rheumatol 31:969\u2013973","journal-title":"Clin Exp Rheumatol"},{"key":"4833_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrrheum.2013.95","volume":"9","author":"CA Silva","year":"2013","unstructured":"Silva CA, Aikawa NE, Bonfa E (2013) Vaccinations in juvenile chronic inflammatory diseases: an update. Nat Rev Rheumatol 9:532\u2013543","journal-title":"Nat Rev Rheumatol"},{"key":"4833_CR20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1136\/ard.2003.013201","volume":"63","author":"O Kasapcopur","year":"2004","unstructured":"Kasapcopur O, Cullu F, Kamburoglu-Goksel A, Cam H, Akdenizli E, Calykan S et al (2004) Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 63:1128\u20131130","journal-title":"Ann Rheum Dis"},{"key":"4833_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/14397595.2015.1085608","volume":"26","author":"Y Nerome","year":"2016","unstructured":"Nerome Y, Akaike H, Nonaka Y, Takezaki T, Kubota T, Yamato T et al (2016) The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment. Mod Rheum 26:368\u2013371","journal-title":"Mod Rheum"},{"key":"4833_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","volume":"71","author":"MW Heijstek","year":"2012","unstructured":"Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM (2012) Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Ann Rheum Dis 71:948\u2013954","journal-title":"Ann Rheum Dis"},{"key":"4833_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10067-018-4367-9","volume":"38","author":"D Aygun","year":"2019","unstructured":"Aygun D, Sahin S, Adrovic A, Barut K, Cokugras H, Camc\u0131oglu Y et al (2019) The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study. Clin Rheum 38:1025\u20131030","journal-title":"Clin Rheum"},{"key":"4833_CR24","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/art.37866","volume":"65","author":"T Beukelman","year":"2013","unstructured":"Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG et al (2013) Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum 65:1384\u20131389","journal-title":"Arthritis Rheum"},{"key":"4833_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-018-1780-z","volume":"20","author":"J Swart","year":"2018","unstructured":"Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E et al (2018) Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther 20:285","journal-title":"Arthritis Res Ther"},{"key":"4833_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12969-016-0095-3","volume":"14","author":"R Leuvenink","year":"2016","unstructured":"Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M et al (2016) Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Pediatr Rheum 14:34","journal-title":"Pediatr Rheum"},{"key":"4833_CR27","first-page":"164","volume":"38","author":"M Bizjak","year":"2020","unstructured":"Bizjak M, Blazina \u0160, Zajc Avramovi\u010d M, Markelj G, Av\u010din T, Toplak N (2020) Vaccination coverage in children with rheumatic diseases. Clin Exp Rheum 38:164\u2013170","journal-title":"Clin Exp Rheum"},{"key":"4833_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0149-2918(01)80044-8","volume":"23","author":"T Coates","year":"2001","unstructured":"Coates T, Wilson R, Patrick G, Andr\u00e9 F, Watson V (2001) Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 23:392\u2013403","journal-title":"Clin Ther"},{"key":"4833_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-015-2341-x","volume":"34","author":"R Orlando","year":"2015","unstructured":"Orlando R, Foggia M, Maraolo AE, Mascolo S, Palmiero G, Tambaro O et al (2015) Prevention of hepatitis B virus infection: from the past to the future. Eur J Clin Microbiol Infect Dis 34:1059\u20131070","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4833_CR30","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1016\/j.vaccine.2017.07.025","volume":"35","author":"DP Patel","year":"2017","unstructured":"Patel DP, Treat JR, Castelo-Socio L (2017) Decreased hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea. Vaccine 35:4499\u20134500","journal-title":"Vaccine"},{"key":"4833_CR31","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1080\/21645515.2015.1069448","volume":"11","author":"R Opri","year":"2015","unstructured":"Opri R, Veneri D, Mengoli C, Zanoni G (2015) Immune response to Hepatitis B vaccine in patients with celiac disease: a systematic review and meta-analysis. Hum Vaccines Immunother 11:2800\u20132805","journal-title":"Hum Vaccines Immunother"},{"key":"4833_CR32","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00431-012-1815-4","volume":"171","author":"C Aypak","year":"2012","unstructured":"Aypak C, Y\u00fcce A, Y\u0131k\u0131lkan H, G\u00f6rpelio\u011flu S (2012) Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to 12-year-old children. Eur J Pediatr 171:1761\u20131766","journal-title":"Eur J Pediatr"},{"key":"4833_CR33","first-page":"47","volume":"46","author":"A S\u00fcleyman","year":"2012","unstructured":"S\u00fcleyman A, G\u00f6k\u00e7ay G, Badur S, Ayk\u0131n S, K\u0131l\u0131\u00e7 G, Tamay Z et al (2012) Evaluation of serological status of children following hepatitis B vaccination during infancy. Mikrobiyol Bul 46:47\u201356","journal-title":"Mikrobiyol Bul"},{"key":"4833_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/acr.23709","volume":"71","author":"K Minden","year":"2019","unstructured":"Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P et al (2019) Time of disease-modifying antirheumatic drug start in juvenile idiopathic arthritis and the likelihood of a drug-free remission in young adulthood. Arthritis Care Res 71:471\u2013481","journal-title":"Arthritis Care Res"},{"key":"4833_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1517\/14712598.2011.554810","volume":"11","author":"MB Carroll","year":"2011","unstructured":"Carroll MB (2011) The impact of biologic response modifiers on hepatitis B virus infection. Expert Opin Biol Ther 11:533\u2013544","journal-title":"Expert Opin Biol Ther"},{"key":"4833_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M et al (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79:39\u201352","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04833-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04833-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T11:56:47Z","timestamp":1698062207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04833-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04833-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to Good Clinical Practice guidelines and the Declaration of Helsinki, with necessary approvals from the local Ethical Committee (B.10.1.TKH.4.34.H.GP.0.01\/353).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Legal guardians signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}